Lifestyle
Semaglutide Helps 40% of Children Move Below Obesity Threshold in New Trial
A Phase 3 trial found that around 40% of children receiving weekly semaglutide injections moved below the obesity threshold after 68 weeks…
2 stories
A Phase 3 trial found that around 40% of children receiving weekly semaglutide injections moved below the obesity threshold after 68 weeks…
Novo Nordisk has launched Awiqli, the world's first once-weekly insulin in India. Here's how it works, who can use it, its benefits…
The stories that matter, in your inbox by 8 AM. Free, no spam.